Charles Schwab Investment Management Inc. Acquires 6,384 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Charles Schwab Investment Management Inc. grew its holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 1.5% in the 4th quarter, Holdings Channel reports. The fund owned 440,250 shares of the company’s stock after purchasing an additional 6,384 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Rhythm Pharmaceuticals were worth $24,645,000 […]
